Chrysin Ameliorates Influenza Virus Infection in the Upper Airways by Repressing Virus-Induced Cell Cycle Arrest and Mitochondria-Dependent Apoptosis

Ying Liu, Xun Song, Chenyang Li, Hao Hu, Wanlin Li, Lu Wang, Jing Hu, Chenghui Liao, Hanbai Liang, Zhendan He, Liang YeFrontiers in Immunology 2022 · DOI

TL;DR

Researchers have discovered that Chrysin, a natural flavonoid found in honey and propolis, inhibits H1N1 influenza replication by preventing the virus from hijacking the host cell’s life cycle. Unlike many antivirals, it works indirectly by reducing oxidative stress and blocking virus-induced cell death, specifically showing high efficacy in the upper respiratory tract.

What Problem Does This Paper Address?

Influenza A virus (IAV) remains a persistent global health threat, causing hundreds of thousands of deaths annually. While vaccines and antivirals like Oseltamivir exist, the rapid mutation of the virus leads to frequent drug resistance.

The scientific community has long known that IAV doesn't just enter a cell; it actively manipulates host machinery—specifically "freezing" the cell cycle and triggering programmed cell death (apoptosis)—to maximize its own replication. While Chrysin was previously known to have antiviral properties, the exact mechanism and its effectiveness in a living organism (in vivo) remained a mystery. This paper investigates whether Chrysin can protect the host by interfering with these viral "hijacking" tactics.

Methods

The study employed a multi-disciplinary approach combining molecular biology and animal models:

  • Cell Models: The team used MDCK (canine kidney) and A549 (human lung epithelial) cells infected with two different H1N1 strains.
  • Molecular Analysis: They utilized Biolayer Interferometry (BLI) to check if Chrysin binds directly to viral proteins and RT-qPCR/Western Blotting to track gene and protein expression.
  • Flow Cytometry: This was essential for measuring Reactive Oxygen Species (ROS) levels, cell cycle distribution, and apoptosis rates.
  • In Vivo Testing: C57BL/6 mice were infected intranasally and treated with Chrysin via intragastric administration to observe its effects on different parts of the respiratory system.

Datasets

As a biological study, the "datasets" consist of standardized biological models:

  • Cell Lines: MDCK and A549.
  • Virus Strains: H1N1 strains A/Jilin/SW1182/2013 and A/PR/8/34.
  • Animal Model: C57BL/6 mice (6-8 weeks old).

Key Insights and Ideas

The researchers uncovered several "aha" moments that differentiate Chrysin from typical antivirals:

  • An Indirect Mechanism: Surprisingly, Chrysin does not bind directly to viral proteins (like Hemagglutinin or Neuraminidase), nor does it boost the body's innate interferon response. Instead, it acts on the host cell's internal environment.
  • Breaking the Cell Cycle Arrest: IAV typically stops host cells in the G0/G1 phase to favor its own growth. Chrysin "unfreezes" the cell by downregulating the inhibitors P53 and P21 and promoting the activation of Cyclin D1/CDK4.
  • Mitochondrial Protection: The virus usually triggers a "suicide" pathway in cells. Chrysin maintains the balance of Bax/Bcl-xl proteins, preventing the mitochondria from releasing the signals that lead to cell death (caspase-3/9 activation).
  • ROS as the Master Switch: The study suggests that Chrysin’s ability to reduce Reactive Oxygen Species (ROS)—essentially cellular "exhaust"—is the primary driver behind its ability to stop cell cycle arrest and apoptosis.

Key Results

  • In Vitro Efficacy: Chrysin significantly reduced viral titers in a dose-dependent manner without being toxic to the host cells (up to 12 μM).
  • Upper Airway Success: In mice, Chrysin treatment led to a 10-fold reduction in viral titers in the snout (upper respiratory tract) compared to untreated controls.
  • Spatial Specificity: Interestingly, the treatment was highly effective in the upper airways but showed no significant impact on viral levels in the lungs or overall survival rates in a lethal infection model.
  • Protein Restoration: Western blots confirmed that Chrysin restored Cyclin D1 and E1 levels, which are normally depleted during an active flu infection.

Limitations and Future Work

The most notable limitation is that Chrysin failed to protect the lower respiratory tract (the lungs) or prevent death in mice challenged with a lethal dose. The authors attribute this to Chrysin’s poor solubility and bioavailability when administered orally.

Future research may focus on:

  1. Delivery Systems: Developing nasal sprays or inhalation-based delivery to get Chrysin directly into the lungs.
  2. Transmission Studies: Since Chrysin works so well in the snout, it might be highly effective at preventing the spread of the virus from person to person, even if it doesn't cure a deep-seated lung infection.
  3. Combination Therapy: Testing Chrysin alongside existing antivirals to see if they provide a synergistic effect.

Summary updated

Abstract

Chrysin has been proven to possess antiviral properties, but the precise underlying anti-influenza mechanism and its anti-influenza efficacy <i>in vivo</i> are largely unclear. In this study, we investigated the involvement of chrysin in the blockade of cell cycle and apoptosis in distinct cell lines subjected to two H1N1 influenza A virus (IAV) strains, as well as its anti-IAV activity <i>in vivo</i>. Here, we found an early unidentified finding that chrysin strongly impeded IAV replication through a mechanism that was autonomous of innate antiviral immune activation and viral protein interaction. Surprisingly, chrysin can suppress IAV-induced cell cycle arrest in the G0/G1 phase by downregulating the expression levels of P53 and P21 while promoting Cyclin D1/CDK4 and Cyclin E1/CDK2 activation. Furthermore, chrysin dramatically inhibited the IAV-triggered mitochondrial apoptotic pathway by altering the balance of Bax/Bcl-xl and reducing caspase-9 and caspase-3 activation. Accumulated reactive oxygen species (ROS) reduction may contribute to the inhibitory role of chrysin in cell cycle arrest and apoptosis following IAV infection. Notably, chrysin preferably inhibited IAV replication in the upper respiratory tract, indicating that it might be a promising drug for restraining the spread of respiratory viruses.
BibTeX
@inproceedings{liu2022chrysin,
  author = {Ying Liu and Xun Song and Chenyang Li and Hao Hu and Wanlin Li and Lu Wang and Jing Hu and Chenghui Liao and Hanbai Liang and Zhendan He and Liang Ye},
  title = {{Chrysin Ameliorates Influenza Virus Infection in the Upper Airways by Repressing Virus-Induced Cell Cycle Arrest and Mitochondria-Dependent Apoptosis}},
  booktitle = {Frontiers in Immunology},
  year = {2022},
  doi = {10.3389/fimmu.2022.872958},
}
Figure